Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-074196
Filing Date
2025-05-19
Accepted
2025-05-19 14:38:03
Documents
2
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5913
2 EX-24.1 rgen-ex24_1.htm EX-24.1 6848
  Complete submission text file 0000950170-25-074196.txt   14239
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REPLIGEN CORP. 41 SEYON STREET, BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address
Mhatre Rohin (Reporting) CIK: 0001798735 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 25963333